Mometasone Furoate Patent Expiration
Mometasone Furoate is Used for treating nasal polyps in adult patients who have had ethmoid sinus surgery using a corticosteroid-eluting (mometasone furoate) implant. It was first introduced by Organon Llc A Sub Of Organon And Co
Mometasone Furoate Patents
Given below is the list of patents protecting Mometasone Furoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sinuva | US10232152 | Systems, devices, and method for treating a sinus condition | Nov 24, 2034 | Intersect Ent Inc |
| Sinuva | US10406332 | Systems, devices, and method for treating a sinus condition | Mar 13, 2034 | Intersect Ent Inc |
| Sinuva | US8763222 | Methods and devices for crimping self-expanding devices | Feb 08, 2032 | Intersect Ent Inc |
| Sinuva | US10357640 | Expandable devices and methods for treating a nasal or sinus condition | Oct 03, 2031 | Intersect Ent Inc |
| Sinuva | US8025635 | Device and methods for treating paranasal sinus conditions | Jun 12, 2027 | Intersect Ent Inc |
| Sinuva | US7544192 | Sinus delivery of sustained release therapeutics | Nov 29, 2026 | Intersect Ent Inc |
| Sinuva | US9585681 | Device and methods for treating paranasal sinus conditions | Apr 04, 2026 | Intersect Ent Inc |
| Sinuva | US7662141 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7713255 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7951130 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7951131 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US7951133 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Sinuva | US8109918 | Sinus delivery of sustained release therapeutics |
Mar 12, 2024
(Expired) | Intersect Ent Inc |
| Asmanex Twisthaler |
US6503537 (Pediatric) | Preparation of powder agglomerates |
Sep 17, 2018
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US8173172 (Pediatric) | Preparation of powder agglomerates |
Sep 17, 2018
(Expired) | Organon Llc |
| Nasonex |
US6127353 (Pediatric) | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
Apr 03, 2018
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6503537 | Preparation of powder agglomerates |
Mar 17, 2018
(Expired) | Organon Llc |
| Asmanex Twisthaler | US8173172 | Preparation of powder agglomerates |
Mar 17, 2018
(Expired) | Organon Llc |
| Nasonex | US6127353 | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
Oct 03, 2017
(Expired) | Organon Llc |
| Asmanex Hfa | US6068832 | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
Aug 27, 2017
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6240918 (Pediatric) | Powdered medication inhaler |
Aug 20, 2017
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6240918 | Powdered medication inhaler |
Feb 20, 2017
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5829434 (Pediatric) | Inhaler for powdered medications |
May 03, 2016
(Expired) | Organon Llc |
| Asmanex Twisthaler | US5829434 | Inhaler for powdered medications |
Nov 03, 2015
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5687710 (Pediatric) | Inhaler for powdered medications having spiral deagglomeration chamber |
May 18, 2015
(Expired) | Organon Llc |
| Asmanex Twisthaler | US5687710 | Inhaler for powdered medications having spiral deagglomeration chamber |
Nov 18, 2014
(Expired) | Organon Llc |
| Asmanex Hfa |
US5889015 (Pediatric) | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa |
US6057307 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa |
US6365581 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5889015 (Pediatric) | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6057307 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6365581 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6677322 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US6949532 (Pediatric) | Use of mometasone furoate for treating airway passage and lung diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Nasonex |
US5837699 (Pediatric) | Use of mometasone furoate for treating upper airway passage diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Nasonex |
US6723713 (Pediatric) | Use of mometasone furoate for treating upper airway diseases |
Jul 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa | US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa | US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Hfa | US6365581 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US5889015 | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6057307 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6365581 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6677322 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler | US6949532 | Use of mometasone furoate for treating airway passage and lung diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Nasonex | US5837699 | Use of mometasone furoate for treating upper airway passage diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Nasonex | US6723713 | Use of mometasone furoate for treating upper airway diseases |
Jan 27, 2014
(Expired) | Organon Llc |
| Asmanex Twisthaler |
US5394868 (Pediatric) | Inhalation device for powdered medicaments |
Dec 25, 2012
(Expired) | Organon Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Mometasone Furoate's patents.
Latest Legal Activities on Mometasone Furoate's Patents
Given below is the list recent legal activities going on the following patents of Mometasone Furoate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification Critical | 12 Apr, 2024 | US8109918 |
| Mail O.P. Petition Decision | 12 Apr, 2024 | US8109918 |
| Mail-Record Petition Decision of Granted to Make Entity Status large | 09 Apr, 2024 | US8109918 |
| O.P. Petition Decision | 08 Apr, 2024 | US8109918 |
| Record Petition Decision of Granted to Make Entity Status large | 08 Apr, 2024 | US8109918 |
| Payment of Maintenance Fee under 1.28(c) | 13 Feb, 2024 | US8109918 |
| Petition Entered | 13 Feb, 2024 | US8109918 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 13 Feb, 2024 | US8109918 |
| Change in Power of Attorney (May Include Associate POA) Critical | 09 Feb, 2024 | US8109918 |
| Email Notification Critical | 09 Feb, 2024 | US8109918 |
Mometasone Furoate's Family Patents
Explore Our Curated Drug Screens
Mometasone Furoate Generic API Manufacturers
Several generic applications have been filed for Mometasone Furoate. The first generic version for Mometasone Furoate was by Padagis Us Llc and was approved on Mar 18, 2002. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Nov 22, 2024.
Given below is the list of companies who have filed for Mometasone Furoate generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05MG/SPRAY | spray, metered | Discontinued | NASAL | N/A | Jun 14, 2023 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05MG/SPRAY | spray, metered | Prescription | NASAL | AB | Apr 3, 2017 |
3. ANDA REPOSITORY
Anda Repository Llc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Anda Repository.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Discontinued | TOPICAL | N/A | Apr 18, 2007 |
4. APOTEX
Apotex Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05MG/SPRAY | spray, metered | Discontinued | NASAL | N/A | Apr 23, 2024 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
5. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05MG/SPRAY | spray, metered | Over the counter | NASAL | N/A | Nov 22, 2024 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
6. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | lotion | Discontinued | TOPICAL | N/A | Nov 21, 2007 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
7. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Encube.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | lotion | Discontinued | TOPICAL | N/A | Nov 21, 2007 |
Manufacturing Plant Locations New
Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
8. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | lotion | Prescription | TOPICAL | AB | Nov 29, 2007 |
9. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1%
(reference standard) | cream | Prescription | TOPICAL | AB | May 28, 2008 |
10. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | lotion | Prescription | TOPICAL | AB | Aug 9, 2010 |
11. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1%
(reference standard) | lotion | Prescription | TOPICAL | AB | Apr 6, 2005 |
Manufacturing Plant Locations New
Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Israel |
| |||
12. PADAGIS US
Padagis Us Llc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | ointment | Prescription | TOPICAL | AB | Mar 18, 2002 |
Manufacturing Plant Locations New
Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
13. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | lotion | Prescription | TOPICAL | AB | Mar 15, 2006 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||
14. TORRENT
Torrent Pharmaceuticals Ltd has filed for 1 generic for Mometasone Furoate. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | ointment | Prescription | TOPICAL | AB | Jul 13, 2018 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||